M. Andreeff
- Hematology top 1%
- Acute Myeloid Leukemia Research 16
- Hematopoietic Stem Cell Transplantation 6
- Chronic Myeloid Leukemia Treatments 5
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research 10
- Virus-based gene therapy research 2
- Oncology top 5%
- Immunology top 10%
- Immunodeficiency and Autoimmune Disorders 2
-
- Acute Lymphoblastic Leukemia research 5
-
- Retinoids in leukemia and cellular processes 5
- Co-authors
- Richard ChamplinJennifer L. DembinskiMaria da Graça Cabreira-HansenMatus StudenyClaudia ZompettaF. MariniB. Nebiyou BekeleHagop M. Kantarjian
- Cited by
- HematologyGeneticsOncology
- Journals
- Blood (8 papers)Journal of Clinical Oncology (6 papers)Clinical Infectious Diseases (1 paper)
- Partner nations
- United StatesMalaysiaItaly
In The Last Decade
M. Andreeff
38 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 95
- Hematology 1.0k
- Genetics 881
- Oncology 680
- Immunology 371
- Pathology and Forensic Medicine 243
Countries citing papers authored by M. Andreeff
This map shows the geographic impact of M. Andreeff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Andreeff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Andreeff more than expected).
Fields of papers citing papers by M. Andreeff
This network shows the impact of papers produced by M. Andreeff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Andreeff. The network helps show where M. Andreeff may publish in the future.
Co-authorship network
The 25 scholars most cited alongside M. Andreeff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 2 | |
| 2 | 2011 | 6 | |
| 3 | 2010 | 159 | |
| 4 | 2010 | 28 | |
| 5 | 2009 | 2 | |
| 6 | 2008 | 108 | |
| 7 | 2005 | 41 | |
| 8 | 2004 | 42 | |
| 9 | Mesenchymal Stem Cells: Potential Precursors for Tumor Stroma and Targeted-Delivery Vehicles for Anticancer Agentsbreakdown → | 2004 | 670 |
| 10 | 1995 | 100 | |
| 11 | 1995 | 16 | |
| 12 | 1995 | 95 | |
| 13 | Chromosome 17 numerical abnormalities in 55 patients with non-Hodgkin's lymphoma: a fluorescence in situ hybridization study. | 1995 | 5 |
| 14 | 1993 | 5 | |
| 15 | 1991 | 227 | |
| 16 | 1983 | 2 | |
| 17 | 1982 | 42 | |
| 18 | Kinetic and biochemical modulation of pyrimidine antimetabolites in therapy of acute leukemia | 1981 | 1 |
| 19 | Characterization of cultured human tumor cell lines by flow cytometry DNA stemline. | 1981 | 3 |
| 20 | 1980 | 2 |
About M. Andreeff
M. Andreeff is a scholar working on Hematology, Genetics and Oncology, having authored 38 papers that have together received 2.4k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (16 papers), Chronic Lymphocytic Leukemia Research (10 papers), Hematopoietic Stem Cell Transplantation (6 papers), Chronic Myeloid Leukemia Treatments (5 papers), Acute Lymphoblastic Leukemia research (5 papers), Retinoids in leukemia and cellular processes (5 papers), Virus-based gene therapy research (2 papers) and Immunodeficiency and Autoimmune Disorders (2 papers). The work is most often cited by research in Hematology (1.0k citations), Genetics (881 citations) and Oncology (680 citations). M. Andreeff has collaborated with scholars based in United States, Malaysia and Italy. Frequent co-authors include Richard Champlin, Jennifer L. Dembinski, Maria da Graça Cabreira-Hansen, Matus Studeny, Claudia Zompetta, F. Marini, B. Nebiyou Bekele, Hagop M. Kantarjian, Nadeem Q. Mirza and Donna Przepiorka. Their work appears in journals such as Blood, Journal of Clinical Oncology, Clinical Infectious Diseases, JNCI Journal of the National Cancer Institute and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.